Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?

References

• Hetzel L, Smith A. The 65 years and over population, Census 2000 Brief, C2KBR/01-10Washington, DC: US Census Bureau, 2001. https://www.census.gov/prod/2001pubs/c2kbr01-10.pdf . Accessed 29/01/2010
   Google Scholar
• UK census, 2001. http://www.statistics.gov.uk/cci/nugget.asp?id=185 . Accessed 30/06/2009
   Google Scholar
• Barlow DH, Samsioe G, van Geelen JM. A study of European women's experience of the problems of urogenital ageing and its management. Maturitas 1997;27:239–47
   Google Scholar
• Iosif CS, Bekassy Z. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984;63:257–60
   Google Scholar
• Jahanlu D, Hunskaar S. Prevalence of urinary incontinence during 10 years in a prospective cohort of middle aged women. San Francisco: ICS, 2009. http://www.icsoffice.org/ASPNET_Membership/Membership/Abstracts/Publish/47/000125.pdf. Accessed 30/01/2010
   Google Scholar
• Jackson SL, Scholes D, Boyko EJ, Abraham L, Fihn SD. Predictors of urinary incontinence in a prospective cohort of postmenopausal women. Obstet Gynecol 2006;108:855–62
   Google Scholar
• Jackson SL, Boyko EJ, Scholes D, et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004;117:903–11
   Google Scholar
• Oskay UY, Beji NK, Yalcin O. A study on urogenital complaints of postmenopausal women aged 50 and over. Acta Obstet Gynecol Scand 2005;84:72–8
   Google Scholar
• Turner DA, Shaw C, McGrother CW, Dallosso HM, Cooper NJ. The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK. BJU Int 2004;93:1246–52
   Google Scholar
• Quinn SD, Domoney C. The effects of hormones on urinary incontinence in postmenopausal women. Climacteric 2009;12:106–13
   Google Scholar
• Van Geelen JM, Doesburg WH, Thomas CM, Martin CB Jr. Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol 1981;141:384–92
   Google Scholar
• Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol 1981;141:817–20
   Google Scholar
• Al-Baghdadi O, Ewies AA. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 2009;12:91–105
   Google Scholar
• Kalogeraki A, Tamiolakis D, Relakis K, et al. Cigarette smoking and vaginal atrophy in postmenopausal women. In Vivo 1996;10:597–600
   Google Scholar
• Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737–44
   Google Scholar
• Thomas TM, Plymat KR, Blannin J, Meade TW. Prevalence of urinary incontinence. Br Med J 1980;281:1243–5
   Google Scholar
• Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92:722–7
   Google Scholar
• Jarmy-Di Bella ZI, Girao MJ, Sartori MF, et al. Power Doppler of the urethra in continent or incontinent, pre- and postmenopausal women. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:148–54; discussion 54–5
   Google Scholar
• Kobata SA, Girao MJ, Baracat EC, et al. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Doppler velocimetry analysis. Maturitas 2008;61:243–7
   Google Scholar
• Rud T, Andersson KE, Asmussen M, Hunting A, Ulmsten U. Factors maintaining the intraurethral pressure in women. Invest Urol 1980;17:343–7
   Google Scholar
• Beisland HO, Fossberg E, Moer A, Sander S. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation. Urol Int 1984;39:211–16
   Google Scholar
• Fantl JA, Cardozo L, McClish DK. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1994;83:12–18
   Google Scholar
• Gebhart JB, Rickard DJ, Barrett TJ, et al. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 2001;185:1325–30; discussion 30–1
   Google Scholar
• Xie Z, Shi H, Zhou C, et al. Alterations of estrogen receptor-alpha and -beta in the anterior vaginal wall of women with urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2007;134:254–8
   Google Scholar
• Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol 2004;6(Suppl 3):S3–9
   Google Scholar
• Ewies AA, Al-Azzawi F, Thompson J. Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis. Hum Reprod 2003;18:2189–95
   Google Scholar
• Jackson S, James M, Abrams P. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. Br J Obstet Gynaecol 2002;109:339–44
   Google Scholar
• Versi E, Cardozo L, Brincat M, et al. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1988;95:147–52
   Google Scholar
• Mulholland SG, Qureshi SM, Fritz RW, Silverman H. Effect of hormonal deprivation on the bladder defense mechanism. J Urol 1982;127:1010–13
   Google Scholar
• Zoubina EV, Mize AL, Alper RH, Smith PG. Acute and chronic estrogen supplementation decreases uterine sympathetic innervation in ovariectomized adult virgin rats. Histol Histopathol 2001;16:989–96
   Google Scholar
• Levin RM, Jacobowitz D, Wein AJ. Autonomic innervation of rabbit urinary bladder following estrogen administration. Urology 1981;17:449–53
   Google Scholar
• Batra S, Andersson KE. Oestrogen-induced changes in muscarinic receptor density and contractile responses in the female rabbit urinary bladder. Acta Physiol Scand 1989;137:135–41
   Google Scholar
• Brown JS, Grady D, Ouslander JG, et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999;94:66–70
   Google Scholar
• Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10:509–15
   Google Scholar
• Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;CD005131
   Google Scholar
• Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753–6
   Google Scholar
• Notelovitz M. Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration. Maturitas 1995;22(Suppl):S31–3
   Google Scholar
• Stamey TA, Sexton CC. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol 1975;113:214–17
   Google Scholar
• Molander U, Milsom I, Ekelund P, Mellstrom D, Eriksson O. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas 1990;12:113–20
   Google Scholar
• Ballagh SA. Vaginal hormone therapy for urogenital and menopausal symptoms. Semin Reprod Med 2005;23:126–40
   Google Scholar
• Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003;CD001405
   Google Scholar
• Brown JS, Vittinghoff E, Kanaya AM, et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001;98:1045–52
   Google Scholar
• Cardozo L, Benness C, Abbott D. Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998;105:403–7
   Google Scholar
• Kirkengen AL, Andersen P, Gjersoe E, et al. Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care 1992;10:139–42
   Google Scholar
• Ouslander JG, Greendale GA, Uman G, et al. Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents. J Am Geriatr Soc 2001;49:803–7
   Google Scholar
• Grodstein F, Lifford K, Resnick NM, Curhan GC. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 2004;103:254–60
   Google Scholar
• Steinauer JE, Waetjen LE, Vittinghoff E, et al. Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol 2005;106:940–5
   Google Scholar
• Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935–48
   Google Scholar
• Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CM. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 2009; CD001405
   Google Scholar
• Miodrag A, Castleden CM, Vallance TR. Sex hormones and the female urinary tract. Drugs 1988;36:491–504
   Google Scholar
• Kristiansson P, Samuelsson E, von Schoultz B, Svardsudd K. Reproductive hormones and stress urinary incontinence in pregnancy. Acta Obstet Gynecol Scand 2001;80:1125–30
   Google Scholar
• Section of Female and Reconstructive Urology of the British Association of Urological Surgeons and the British Society of Urogynaecology. Implementation of the NICE guidance for the management of urinary incontinence in women 2007. http://www.rcog.org.uk/files/rcog-corp/uploaded-files/nice_guidance_implementation_guide.pdf . Accessed 23/09/2009
   Google Scholar
• Pitkin J, Rees M. Urogenital atrophy. Menopause Int 2008;14:136–7
   Google Scholar
• Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Br J Obstet Gynaecol 2000;107:1029–34
   Google Scholar
• Dessole S, Rubattu G, Ambrosini G, et al. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 2004;11:49–56
   Google Scholar
• Long CY, Liu CM, Hsu SC, et al. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women. Fertil Steril 2006;85:155–60
   Google Scholar
• Bhatia NN, Bergman A, Karram MM. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989;160:176–81
   Google Scholar
• National Institute for Health and Clinical Excellence. Urinary incontinence 2006. http://www.nice.org.uk/nicemedia/pdf/CG40fullguideline.pdf. Accessed 19/09/2009
   Google Scholar
• Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 2004;83:892–97
   Google Scholar
• Henriksson L, Stjernquist M, Boquist L, Cedergren I, Selinus I. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am J Obstet Gynecol 1996;174:85–92
   Google Scholar
• Zullo MA, Plotti F, Calcagno M, et al. Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial. Menopause 2005;12:421–7
   Google Scholar
• Simunic V, Banovic I, Ciglar S, et al. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003;82:187–97
   Google Scholar
• Cardozo LD, Wise BG, Benness CJ. Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women – a double-blind placebo-controlled study. J Obstet Gynaecol 2001;21:383–5
   Google Scholar
• Serati M, Salvatore S, Uccella S, Cardozo L, Bolis P. Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity? Eur Urol 2009;55:713–19
   Google Scholar
• Rembratt A. Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity? Eur Urol 2009;55:719
   Google Scholar
• Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072–9
   Google Scholar
• Felding C, Mikkelsen AL, Clausen HV, Loft A, Larsen LG. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial. Maturitas 1992;15:241–9
   Google Scholar
• Mikkelsen AL, Felding C, Clausen HV. Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial. Gynecol Obstet Invest 1995;40:125–8
   Google Scholar
• Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: Third report of the Hormones and Urogenital Therapy (HUT) Committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:15–20
   Google Scholar
• Rigg LA, Milanes B, Villanueva B, Yen SS. Efficacy of intravaginal and intranasal administration of micronized estradiol-17beta. J Clin Endocrinol Metab 1977;45:1261–4
   Google Scholar
• Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol 1998;20:211–15
   Google Scholar
• Schmidt G, Andersson SB, Nordle O, Johansson CJ, Gunnarsson PO. Release of 17-beta-oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation. Gynecol Obstet Invest 1994;38:253–60
   Google Scholar
• Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431–42
   Google Scholar
• Haspels AA, Luisi M, Kicovic PM. Endocrinological and clinical investigations in post-menopausal women following administration of vaginal cream containing oestriol. Maturitas 1981;3:321–7
   Google Scholar
• Electronic-Medicines-Compendium 2008. http://emc.medicines.org.uk/medicine/1387/SPC/Ovestin+Cream/#PHARMACOKINETIC_PROPS. Accessed 30/06/2009
   Google Scholar
• Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156–61
   Google Scholar
• Bachmann G. The estradiol vaginal ring – a study of existing clinical data. Maturitas 1995;22(Suppl):S21–9
   Google Scholar
• Anderson JN, Peck EJ Jr, Clark JH. Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology 1975;96:160–7
   Google Scholar
• Luisi M, Franchi F, Kicovic PM. A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy. Maturitas 1980;2:311–19
   Google Scholar
• Nachtigall LE. Clinical trial of the estradiol vaginal ring in the U.S. Maturitas 1995;22(Suppl):S43–7
   Google Scholar
• British National Formulary. Preparations for vaginal atrophyLondon: BMJ Publishing Group, 2008:419–20
   Google Scholar
• Raymundo N, Yu-cheng B, Zi-yan H, et al. Treatment of atrophic vaginitis with topical conjugated equine estrogens in postmenopausal Asian women. Climacteric 2004;7:312–18
   Google Scholar
• Blum M. Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment. Clin Exp Obstet Gynecol 1985;12:1–2
   Google Scholar
• Blum M, Pery J, Gelenter I. Increase in glycosylated hemoglobin (HbA1c) in menopausal women treated with vaginal estrogen cream. Clin Exp Obstet Gynecol 1984;12:72–5
   Google Scholar
• Dugal R, Hesla K, Sordal T, et al. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000;79:293–7
   Google Scholar
• Naessen T, Rodriguez-Macias K. Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women. Am J Obstet Gynecol 2002;186:944–7
   Google Scholar
• Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet 1999;353:1824–8
   Google Scholar
• Johnston SL, Farrell SA, Bouchard C, et al. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26:503–15
   Google Scholar
• Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 1998;16:501–14
   Google Scholar
• Ganz PA, Greendale GA, Petersen L, et al. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 2000;92:1054–64
   Google Scholar
• Chlebowski RT, McTiernan A. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer. J Clin Oncol 1999;17:130–42
   Google Scholar
• Dew J, Eden J, Beller E, et al. A cohort study of hormone replacement therapy given to women previously treated for breast cancer. Climacteric 1998;1:137–42
   Google Scholar
• Dew JE, Wren BG, Eden JA. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric 2003;6:45–52
   Google Scholar
• Vassilopoulou-Sellin R, Theriault R, Klein MJ. Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer. Gynecol Oncol 1997;65:89–93
   Google Scholar
• Antoine C, Liebens F, Carly B, et al. Safety of hormone therapy after breast cancer: a qualitative systematic review. Hum Reprod 2007;22:616–22
   Google Scholar
• Tseng LH, Wang AC, Chang YL, et al. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome. Neurourol Urodyn 2009;28:47–51
   Google Scholar
• Tinelli A, Malvasi A, D'Anna L, et al. Presurgical promestriene therapy in postmenopausal women with stress urinary incontinence. Gynecol Endocrinol 2007;23:445–50
   Google Scholar
• Raz R, Colodner R, Rohana Y, et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003;36:1362–8
   Google Scholar
• Chompootaweep S, Nunthapisud P, Trivijitsilp P, Sentrakul P, Dusitsin N. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study. Clin Pharmacol Ther 1998;64:204–10
   Google Scholar
• Hilton P, Stanton SL. The use of intravaginal oestrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 1983;90:940–44
   Google Scholar